Page last updated: 2024-09-03

wl 19 and exp3174

wl 19 has been researched along with exp3174 in 1 studies

Compound Research Comparison

Studies
(wl 19)
Trials
(wl 19)
Recent Studies (post-2010)
(wl 19)
Studies
(exp3174)
Trials
(exp3174)
Recent Studies (post-2010) (exp3174)
13022362943

Protein Interaction Comparison

ProteinTaxonomywl 19 (IC50)exp3174 (IC50)
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0013
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0027
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0036
Type-1 angiotensin II receptorHomo sapiens (human)0.002
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0075
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.0075

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chakravarty, PK; Chang, RS; Greenlee, WJ; Lotti, VJ; Mantlo, NB; Ondeyka, DL; Patchett, AA; Siegl, PK; Sweet, CS1

Other Studies

1 other study(ies) available for wl 19 and exp3174

ArticleYear
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:1

    Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Imidazoles; Injections, Intravenous; Losartan; Macaca mulatta; Male; Pressoreceptors; Pyridines; Rats; Rats, Inbred Strains; Tetrazoles

1992
chemdatabank.com